Global Next Generation Complement Therapeutics Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Next Generation Complement Therapeutics Global Market Report 2025

Name: Next Generation Complement Therapeutics Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type Of Therapy (Monotherapy, Adjunctive Therapy), By Molecule Type (Biologic, Small Molecule), By Route Of Administration (Intravenous, Oral, Intravitreal, Subcutaneous), By Indication (Paroxysmal Nocturnal Hemoglobinuria, Geographic Atrophy (GA) Secondary To Age-Related Macular Degeneration, Generalized Myasthenia Gravis, Atypical Hemolytic Uremic Syndrome, Other Indications), By Therapeutic Area (Hematology, Ophthalmology, Neurology, Immunology Or Rheumatology, Other Therapeutic Areas) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Next Generation Complement Therapeutics Market Overview

• Next Generation Complement Therapeutics market size has reached to $6.36 billion in 2024

• Expected to grow to $13.24 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%

• Growth Driver: Rise In Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Targeted Anti-Inflammatory Treatments

• Market Trend: Advancing Patient-Centered Therapies For Rare Complement-Mediated Disorders

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next Generation Complement Therapeutics Market?

Next-generation complement therapeutics are advanced treatments designed to precisely modulate the complement system, a key component of the immune response. These new therapies utilize innovative approaches such as antibody-based therapies, RNA medicines, and gene editing to target complex immune and inflammatory disorders more effectively, with fewer side effects than traditional treatments.

The main types of next-generation complement therapeutics are monotherapy and adjunctive therapy. A monotherapy approach means using a complement-targeted drug alone, without combining it with other therapies. These therapies include different molecule types, such as biologics and small molecules, and are administered through several routes of administration, including intravenous, oral, intravitreal, and subcutaneous. These therapies address a range of indications, such as paroxysmal nocturnal hemoglobinuria (PNH), geographic atrophy (GA) secondary to age-related macular degeneration, generalized myasthenia gravis, atypical hemolytic uremic syndrome (aHUS), and others, and are used in several therapeutic areas, including hematology, ophthalmology, neurology, immunology, rheumatology, and others.

Next Generation Complement Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Next Generation Complement Therapeutics Market Size 2025 And Growth Rate?

What Is The Next Generation Complement Therapeutics Market Growth Forecast?

The next generation of complement therapeutics market size is expected to see rapid growth in the next few years. It will grow to $13.24 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to rising investment from venture capital and private equity firms, globalization of clinical trials, increasing use of real-world evidence (RWE), growth in neurodegenerative disease diagnosis rates, and emergence of microbiome-based therapeutics. Major trends in the forecast period include integration of digital biomarkers in clinical trials, adoption of CRISPR and gene editing technologies, development of multi-specific antibodies, adoption of digital twins for patient simulation and precision care, and adoption of 3D bioprinting for personalized drug testing and implants.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Next Generation Complement Therapeutics Market Segmented?

1) By Type Of Therapy: Monotherapy, Adjunctive Therapy

2) By Molecule Type: Biologic, Small Molecule

3) By Route Of Administration: Intravenous, Oral, Intravitreal, Subcutaneous

4) By Indication: Paroxysmal Nocturnal Hemoglobinuria, Geographic Atrophy (GA) Secondary To Age-Related Macular Degeneration, Generalized Myasthenia Gravis, Atypical Hemolytic Uremic Syndrome, Other Indications

5) By Therapeutic Area: Hematology, Ophthalmology, Neurology, Immunology Or Rheumatology, Other Therapeutic Areas

Subsegments:

1) By Monotherapy: C3 Inhibitors, C5 Inhibitors, Factor D Inhibitors, Factor B Inhibitors, C1 Inhibitors, MASP-2 Inhibitors

2) By Adjunctive Therapy: Combination With Immunosuppressants, Combination With Steroids, Combination With Plasma Exchange, Combination With Biologics, Combination With Chemotherapeutics, Combination With Anticoagulants

What Is Driving The Next Generation Complement Therapeutics Market? Rise In Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Targeted Anti-Inflammatory Treatments

The rise in prevalence of chronic diseases is expected to drive the growth of the next-generation complement therapeutics market going forward. Chronic disease is a long-lasting health condition that requires ongoing management to control symptoms and improve quality of life. The rise in chronic diseases is driven by sedentary lifestyles that limit physical activity, disrupt metabolism, and elevate long-term health risks. Next-generation complement therapeutics treat chronic diseases by precisely targeting and modulating the overactive complement system to reduce inflammation and prevent tissue damage. For instance, in January 2022, according to the American Cancer Society, a US-based cancer awareness non-profit organization, in the US, an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths are expected, reaching up to approximately 1,670 deaths on daily basis. Therefore, the rise in prevalence of chronic diseases is driving the growth of the next-generation complement therapeutics market.

Who Are The Major Players In The Global Next Generation Complement Therapeutics Market?

Major companies operating in the next generation complement therapeutics market are AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals, Genentech Inc., Genmab A/S, Mallinckrodt Pharmaceuticals Ltd., Alnylam Pharmaceuticals Inc., Apellis Pharmaceuticals Inc., Omeros Corporation, CANbridge Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Molecular Partners AG, NovelMed Therapeutics Inc., InflaRx GmbH, Amyndas Pharmaceuticals S.A., Kira Pharmaceuticals Inc., ReAlta Life Sciences Inc.

What Are The Key Trends Of The Global Next Generation Complement Therapeutics Market? Advancing Patient-Centered Therapies For Rare Complement-Mediated Disorders

Major companies operating in the next-generation complement therapeutics market are focusing on developing advanced therapeutics, such as novel anti-C5 recycling monoclonal antibodies, to provide more effective and less frequently administered treatments for complement-mediated disorders. An anti-C5 recycling monoclonal antibody is a bioengineered molecule that targets and inhibits complement protein C5 to suppress inflammation while recycling within the body to enhance its half-life and therapeutic impact. For instance, in December 2022, Roche AG, a Switzerland-based pharmaceutical company, announced promising Phase III data from its COMMODORE 3 study, showing that crovalimab, a novel anti-C5 antibody, is effective and well-tolerated in people with PNH in China. The treatment met its main goals of reducing the need for blood transfusions and controlling hemolysis. Designed for subcutaneous use every four weeks, crovalimab offers a convenient, self-administered alternative to current therapies. With Priority Review granted by Chinese regulators, it may soon become a valuable treatment option for PNH, where access to C5 inhibitors is currently very limited.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Next Generation Complement Therapeutics Market? Vertex Pharmaceuticals Acquired Catalyst Biosciences' Complement Portfolio To Boost Next-Gen Immune Therapies

In May 2022, Vertex Pharmaceuticals, a US-based pharmaceutical company, acquired Catalyst Biosciences’ complement portfolio for $60 million. This acquisition expands Vertex’s portfolio in immune-related and rare diseases by giving it access to advanced technologies that target the C3 protein, a key part of the immune system. Catalyst Biosciences is a US-based biopharmaceutical company that provides next-generation complement therapeutics.

What Is The Regional Outlook For The Global Next Generation Complement Therapeutics Market?

North America was the largest region in the next generation complement therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Next Generation Complement Therapeutics Market?

The next-generation complement therapeutics market consists of revenues earned by entities by providing services such as antibody engineering services, preclinical research services, biomanufacturing services, clinical trial management services, and regulatory consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation complement therapeutics market also includes sales of monoclonal antibodies, gene editing tools, small molecule inhibitors, recombinant proteins, and fusion proteins. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Next Generation Complement Therapeutics Industry?

The next generation complement therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next generation complement therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Next Generation Complement Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$7.38 billion
Revenue Forecast In 2034	$13.24 billion
Growth Rate	CAGR of 15.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type Of Therapy, Molecule Type, Route Of Administration, Indication, Therapeutic Area
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals, Genentech Inc., Genmab A/S, Mallinckrodt Pharmaceuticals Ltd., Alnylam Pharmaceuticals Inc., Apellis Pharmaceuticals Inc., Omeros Corporation, CANbridge Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Molecular Partners AG, NovelMed Therapeutics Inc., InflaRx GmbH, Amyndas Pharmaceuticals S.A., Kira Pharmaceuticals Inc., ReAlta Life Sciences Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Next Generation Complement Therapeutics Market Characteristics

3. Next Generation Complement Therapeutics Market Trends And Strategies

4. Next Generation Complement Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Next Generation Complement Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Next Generation Complement Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Next Generation Complement Therapeutics Market Growth Rate Analysis

5.4. Global Next Generation Complement Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Next Generation Complement Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Next Generation Complement Therapeutics Total Addressable Market (TAM)

6. Next Generation Complement Therapeutics Market Segmentation

6.1. Global Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monotherapy

Adjunctive Therapy

6.2. Global Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologic

Small Molecule

6.3. Global Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous

Oral

Intravitreal

Subcutaneous

6.4. Global Next Generation Complement Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Paroxysmal Nocturnal Hemoglobinuria

Geographic Atrophy (GA) Secondary To Age-Related Macular Degeneration

Generalized Myasthenia Gravis

Atypical Hemolytic Uremic Syndrome

Other Indications

6.5. Global Next Generation Complement Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hematology

Ophthalmology

Neurology

Immunology or Rheumatology

Other Therapeutic Areas

6.6. Global Next Generation Complement Therapeutics Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

C3 Inhibitors

C5 Inhibitors

Factor D Inhibitors

Factor B Inhibitors

C1 Inhibitors

MASP-2 Inhibitors

6.7. Global Next Generation Complement Therapeutics Market, Sub-Segmentation Of Adjunctive Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination With Immunosuppressants

Combination With Steroids

Combination With Plasma Exchange

Combination With Biologics

Combination With Chemotherapeutics

Combination With Anticoagulants

7. Next Generation Complement Therapeutics Market Regional And Country Analysis

7.1. Global Next Generation Complement Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Next Generation Complement Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next Generation Complement Therapeutics Market

8.1. Asia-Pacific Next Generation Complement Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next Generation Complement Therapeutics Market

9.1. China Next Generation Complement Therapeutics Market Overview

9.2. China Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next Generation Complement Therapeutics Market

10.1. India Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next Generation Complement Therapeutics Market

11.1. Japan Next Generation Complement Therapeutics Market Overview

11.2. Japan Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next Generation Complement Therapeutics Market

12.1. Australia Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next Generation Complement Therapeutics Market

13.1. Indonesia Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next Generation Complement Therapeutics Market

14.1. South Korea Next Generation Complement Therapeutics Market Overview

14.2. South Korea Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next Generation Complement Therapeutics Market

15.1. Western Europe Next Generation Complement Therapeutics Market Overview

15.2. Western Europe Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next Generation Complement Therapeutics Market

16.1. UK Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next Generation Complement Therapeutics Market

17.1. Germany Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next Generation Complement Therapeutics Market

18.1. France Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next Generation Complement Therapeutics Market

19.1. Italy Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next Generation Complement Therapeutics Market

20.1. Spain Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next Generation Complement Therapeutics Market

21.1. Eastern Europe Next Generation Complement Therapeutics Market Overview

21.2. Eastern Europe Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next Generation Complement Therapeutics Market

22.1. Russia Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next Generation Complement Therapeutics Market

23.1. North America Next Generation Complement Therapeutics Market Overview

23.2. North America Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next Generation Complement Therapeutics Market

24.1. USA Next Generation Complement Therapeutics Market Overview

24.2. USA Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next Generation Complement Therapeutics Market

25.1. Canada Next Generation Complement Therapeutics Market Overview

25.2. Canada Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next Generation Complement Therapeutics Market

26.1. South America Next Generation Complement Therapeutics Market Overview

26.2. South America Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next Generation Complement Therapeutics Market

27.1. Brazil Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next Generation Complement Therapeutics Market

28.1. Middle East Next Generation Complement Therapeutics Market Overview

28.2. Middle East Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next Generation Complement Therapeutics Market

29.1. Africa Next Generation Complement Therapeutics Market Overview

29.2. Africa Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next Generation Complement Therapeutics Market Competitive Landscape And Company Profiles

30.1. Next Generation Complement Therapeutics Market Competitive Landscape

30.2. Next Generation Complement Therapeutics Market Company Profiles

30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Next Generation Complement Therapeutics Market Other Major And Innovative Companies

31.1. Vertex Pharmaceuticals

31.2. Genentech Inc.

31.3. Genmab A/S

31.4. Mallinckrodt Pharmaceuticals Ltd.

31.5. Alnylam Pharmaceuticals Inc.

31.6. Apellis Pharmaceuticals Inc.

31.7. Omeros Corporation

31.8. CANbridge Pharmaceuticals Inc.

31.9. Alexion Pharmaceuticals Inc.

31.10. Molecular Partners AG

31.11. NovelMed Therapeutics Inc.

31.12. InflaRx GmbH

31.13. Amyndas Pharmaceuticals S.A.

31.14. Kira Pharmaceuticals Inc.

31.15. ReAlta Life Sciences Inc.

32. Global Next Generation Complement Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next Generation Complement Therapeutics Market

34. Recent Developments In The Next Generation Complement Therapeutics Market

35. Next Generation Complement Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Next Generation Complement Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Next Generation Complement Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Next Generation Complement Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Next Generation Complement Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Next Generation Complement Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Next Generation Complement Therapeutics Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Next Generation Complement Therapeutics Market, Sub-Segmentation Of Adjunctive Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Next Generation Complement Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Next Generation Complement Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: AstraZeneca PLC Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: Amgen Inc. Financial Performance

Table 81: Regeneron Pharmaceuticals Inc. Financial Performance

Table 82: Astellas Pharma Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Next Generation Complement Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Next Generation Complement Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Next Generation Complement Therapeutics Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Next Generation Complement Therapeutics Market, Sub-Segmentation Of Adjunctive Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Next Generation Complement Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Next Generation Complement Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Next Generation Complement Therapeutics Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Next Generation Complement Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Next Generation Complement Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: AstraZeneca PLC Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: Amgen Inc. Financial Performance

Figure 81: Regeneron Pharmaceuticals Inc. Financial Performance

Figure 82: Astellas Pharma Inc. Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Payment Processor Global Market Report 2025 – By Type (Credit Cards, Debit Cards, E-Wallet Transactions), By Deployment Mode (On-Premises, Cloud-Based), By End-User Industry (Banking Financial Services and Insurance (BFS...

Quantum Technology Global Market Report 2025 – By Type (Hardware, Software, Service), By Application (Cybersecurity, Drug Development, Financial Modeling, Artificial Intelligence, Other Applications), By End-User (Transp...

Payment Processing Solutions Global Market Report 2025 – By Payment Method( eWallet, Credit card, Debit card, Automatic clearing house, Other Methods), By Deployment Type( On-premises, Cloud-based), By Vertical( Banking,...

Mobile Payment Technologies Global Market Report 2025 – By Solutions (Point-Of Sale (POS), In-Store Payments, Remote Payments), By Remote Payments (Internet Payments, SMS Payments, Direct Carrier Billing, Mobile Banking)...

Digital Banking Platform Global Market Report 2025 – By Type (Corporate Banking, Retail Banking), By Component (Platforms, Services), By Banking Mode (Online Banking, Mobile Banking), By Deployment (Cloud, On-Premise) – ...

Bitcoin Payment Ecosystem Global Market Report 2025 – By Component (Hardware, Software, Services), By Application (Decentralize Identity, Decentralize Organization, Smart Contacts, Automated Teller Machine (ATM's), Analy...

Digital Commerce Platform Global Market Report 2025 – By Component (Digital Commerce Platform Solutions, Digital Commerce Platform Services), By Business Model (Business To Consumer (B2C), Business To Business (B2B), Con...

Frequently Asked Questions

What is the definition of the Next Generation Complement Therapeutics market?

How will the Next Generation Complement Therapeutics market drivers and restraints affect the market dynamics? What forces will shape the Next Generation Complement Therapeutics industry going forward?

The market major growth driver - Rise In Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Targeted Anti-Inflammatory Treatments. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Next Generation Complement Therapeutics market?

The next generation complement therapeutics market size has grown rapidly in recent years. It will grow from $6.36 billion in 2024 to $7.38 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to growing adoption of companion diagnostics, an increase in personalized treatment approaches, expansion of telemedicine and digital health platforms, a growing focus on rare and orphan diseases, and increased use of AI and machine learning in drug discovery. The next generation of complement therapeutics market size is expected to see rapid growth in the next few years. It will grow to $13.24 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to rising investment from venture capital and private equity firms, globalization of clinical trials, increasing use of real-world evidence (RWE), growth in neurodegenerative disease diagnosis rates, and emergence of microbiome-based therapeutics. Major trends in the forecast period include integration of digital biomarkers in clinical trials, adoption of CRISPR and gene editing technologies, development of multi-specific antibodies, adoption of digital twins for patient simulation and precision care, and adoption of 3D bioprinting for personalized drug testing and implants. For further insights on this market, request a sample here

How is the Next Generation Complement Therapeutics market segmented?

The next generation complement therapeutics market covered in this report is segmented
1) By Type Of Therapy: Monotherapy, Adjunctive Therapy
2) By Molecule Type: Biologic, Small Molecule
3) By Route Of Administration: Intravenous, Oral, Intravitreal, Subcutaneous
4) By Indication: Paroxysmal Nocturnal Hemoglobinuria, Geographic Atrophy (GA) Secondary To Age-Related Macular Degeneration, Generalized Myasthenia Gravis, Atypical Hemolytic Uremic Syndrome, Other Indications
5) By Therapeutic Area: Hematology, Ophthalmology, Neurology, Immunology Or Rheumatology, Other Therapeutic Areas Subsegments:
1) By Monotherapy: C3 Inhibitors, C5 Inhibitors, Factor D Inhibitors, Factor B Inhibitors, C1 Inhibitors, MASP-2 Inhibitors
2) By Adjunctive Therapy: Combination With Immunosuppressants, Combination With Steroids, Combination With Plasma Exchange, Combination With Biologics, Combination With Chemotherapeutics, Combination With Anticoagulants For further insights on this market, request a sample here

Which region has the largest share of the Next Generation Complement Therapeutics market? What are the other regions covered in the report?

North America was the largest region in the next generation complement therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation complement therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Next Generation Complement Therapeutics market?

What are the key trends in the Next Generation Complement Therapeutics market?

Major trends in this market include Advancing Patient-Centered Therapies For Rare Complement-Mediated Disorders. For further insights on this market, request a sample here.